Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Abstract EN

Recently, there has been an increasing interest in the potential clinical use of several inflammatory indexes, namely, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic-immune-inflammation index (SII).

This study aimed at assessing whether these markers could be early indicators of pulmonary hypertension (PH) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

A total of 185 patients were enrolled in our retrospective study from January 2017 to January 2019.

Receiver operating characteristic curve (ROC) and area under the curve (AUC) were used to evaluate the clinical significance of these biomarkers to predict PH in patients with AECOPD.

According to the diagnostic criterion for PH by Doppler echocardiography, the patients were stratified into two groups.

The study group consisted of 101 patients complicated with PH, and the control group had 84 patients.

The NLR, PLR, and SII values of the PH group were significantly higher than those of the AECOPD one (p<0.05).

The blood biomarker levels were positively correlated with NT-proBNP levels, while they had no significant correlation with the estimated pulmonary arterial systolic pressure (PASP) other than PLR.

NLR, PLR, and SII values were all associated with PH (p<0.05) in the univariate analysis, but not in the multivariate analysis.

The AUC of NLR used for predicting PH was 0.701 and was higher than PLR and SII.

Using 4.659 as the cut-off value of NLR, the sensitivity was 81.2%, and the specificity was 59.5%.

In conclusion, these simple markers may be useful in the prediction of PH in patients with AECOPD.